Clinical Trials Directory

Trials / Completed

CompletedNCT03209609

VEST Venous Graft External Support Pivotal Study

A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
224 (actual)
Sponsor
Vascular Graft Solutions Ltd. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Prospective, multi-center, randomized, within-subject-controlled , trial, enrolling patients with multi vessel atherosclerotic coronary artery disease, scheduled to undergo SVG CABG with arterial grafting of IMA to LAD and two or more saphenous vein grafts. In each patient, one SVG bypass will be randomized to be supported by the VEST, while another will not be supported and serve as control. Thus, the full cohort will provide a basis for comparison between two sets of SVGs: A VEST supported set; and an unsupported set.

Detailed description

Clinical significance: Coronary artery bypass grafting (CABG) remains the gold standard treatment for patients with multi-vessel coronary artery disease. Despite the proposed benefits of multiple arterial grafts, autologous saphenous vein grafts (SVGs) are still the most frequently used bypass conduits in CABG. Progressive SVG failure after CABG remains a key limitation to the long-term success of surgery. Objective: Coronary artery bypass grafting (CABG) remains the gold standard treatment for patients with multi-vessel coronary artery disease. Despite the proposed benefits of multiple arterial grafts, autologous saphenous vein grafts (SVGs) are still the most frequently used bypass conduits in CABG. Progressive SVG failure after CABG remains a key limitation to the long-term success of surgery. Study design: Prospective, multi-center, randomized, within-subject-controlled , trial, enrolling patients with multi vessel atherosclerotic coronary artery disease, scheduled to undergo SVG CABG with arterial grafting of IMA to LAD and two or more saphenous vein grafts. In each patient, one SVG bypass will be randomized to be supported by the VEST, while another will not be supported and serve as control. Thus, the full cohort will provide a basis for comparison between two sets of SVGs: A VEST supported set; and an unsupported set.

Conditions

Interventions

TypeNameDescription
DEVICEVESTExternal support for vein grafts, cobalt chrome braid
PROCEDURECoronary artery bypass vein graftsBypass coronary arteries with autologous saphenous vein grafts

Timeline

Start date
2018-01-09
Primary completion
2020-09-29
Completion
2024-09-25
First posted
2017-07-06
Last updated
2025-02-06

Locations

17 sites across 2 countries: United States, Canada

Regulatory

Source: ClinicalTrials.gov record NCT03209609. Inclusion in this directory is not an endorsement.